International Prospective Study of Klebsiella pneumoniae Bacteremia: Implications of Extended-Spectrum -Lactamase Production in Nosocomial Infections
By David L. Paterson, W. Ko, A. Gottberg, Sunita Mohapatra, J. Casellas, H. Goossens, L. Mulazımoglu, G. Trenholme, K. Klugman, Robert A. Bonomo and 4 more. Annals of Internal Medicine, 2004
673 citations recorded by the source corpus.
Subfields: Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine, Molecular Medicine
View Paper: https://www.semanticscholar.org/paper/152b22096d1923d308ca666e5e8b0fef2d5c326a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Critical Care and Intensive Care Medicine
Citations in the corpus
- Multilocus Sequence Typing of Klebsiella pneumoniae Nosocomial Isolates (2005, background): “pneumoniae isolates are increasingly resistant to multiple antimicrobial agents, including quinolones (5, 23), and, owing to the production of extended-spectrum beta-lactamases (ESBL), extended-spectrum cephalosporins such as ceftazidime (22).”
- Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. (2005, neutral): “5 Resistant D (1) 32 32 32 8 1 Resistant E (1) 32 32 32 16 16 Resistant E (2) 32 32 32 8 2 Susceptible E (3) 32 32 32 16 8 Resistant F (1) 32 32 32 16 16 NA G (1) 32 32 32 4 2 Susceptible H (1) 32 32 32 16 4 Susceptible I (1) 32 32 32 16 16 Resistant A (1) 32 32 32 16 16 Resistant A (2) 32 32 32 16 ”
- Isolation of soil Streptomyces as source antibiotics active against antibiotic-resistant bacteria (2008, background): “…Journal of BioSciences, 200874 EurAsian Journal of BioSciences in hospitals and communities with multi-drug resistance, including broad resistance to first, second, and third generations of penicillin's and cephalosporin's (Urban et al. 2003, Obritsch et al. 2004, Paterson et al. 2004).”
- Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study (2012, background): “Hospital mortality 48 (12) 23 (25) 71 (14) 0.”
- Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. (2013, background): “These include acute severity of illness as indicated by the Pitt bacteraemia score [24], receipt of adequate antimicrobial regimens [22], primary source of infection, and the presence or absence of malignancy and liver cirrhosis [25].”